Glycopyrrolate is generally categorized as an anticholinergic medication that requires careful clinical oversight, particularly in elderly populations or patients with preexisting medical conditions like glaucoma, urinary retention, or severe gastrointestinal motility disorders. Because it inhibits acetylcholine neurotransmission, systemic administration can induce adverse side effects such as severe dry mouth, blurred vision, constipation, urinary hesitancy, and cognitive clouding or confusion in susceptible individuals. When administered via localized topical wipes for hyperhidrosis, systemic absorption is substantially minimized, but clinical evaluation remains essential to weigh potential anticholinergic burdens against therapeutic benefits.